Bozitinib Combined With Chemotherapy as Radical Treatment for Stage IIA-IIIC MET-Altered Non-Small Cell Lung Cancer
Clinical trial NCT07153770 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07153770
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-20
- Primary completion
- 2027-09-20
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.